Sign In

Mark Sterckel

VP Patient Engagement / Chief Patient Officer

Mark Sterckel is an accomplished senior leader in the healthcare industry with extensive experience in patient engagement, innovation, and digital health. He is currently the Managing Director at Sterckel Innovation.13

Professional Experience

Mark has held several key positions throughout his career:

  • VP Patient Engagement / Chief Patient Officer at Alexion Pharmaceuticals (July 2022 - September 2023)1
  • Senior Director Global Patient Advocacy Neurology at Alexion Pharmaceuticals (July 2022 - September 2023)1
  • Sr. Patient Engagement Director at Ferring Pharmaceuticals (July 2020 - July 2022)12
  • Patient Partnership Principal Director Personalised Healthcare at Roche (August 2018 - July 2020)12
  • Director Learning, Patient Support Programs & Innovation Global Medical Affairs at AbbVie (June 2015 - December 2017)12

Expertise and Skills

Mark is known for:

  • Driving patient-centered solutions and innovation in healthcare
  • Developing and implementing patient engagement strategies1
  • Fostering innovation within large teams1
  • Accelerating clinical trial cycles1
  • Mentoring leaders and emphasizing cross-functional value1

Education

Mark's educational background includes:

  • Exponential Technologies Executive program at Singularity University2
  • Innovation practitioner training at ?WhatIf! The Innovation company2
  • Lean Six Sigma Blackbelt training at Abbott University2
  • BSc in Business Administration & Logistics from Amsterdam University of Applied Sciences2

Personal Qualities

Colleagues describe Mark as:

  • Results-driven1
  • An articulate and savvy communicator
  • A skilled team builder1
  • Passionate about patient engagement and innovation1

Mark Sterckel is recognized as an industry veteran with over a decade of experience in patient engagement and healthcare innovation.4

Highlights

Sep 4 · linkedin

At Amazon Web Services AI event in Zurich. Exciting day!🤩

Sep 2 · linkedin

Two years ago, I met Mattia Marco Caruson and Mama Health and learned about their inspiring ambition, which resonated deeply with my own: to uncover the true patient journey and improve the way we serve patients in healthcare.

Since then, Mama Health has evolved into a real-world evidence platform that is leading the new frontier of patient journey mapping (see video below). Using GenAI and process mining, they're able to capture patient experiences in a faster, cheaper and more granular way and we're able to generate insights that can feed into strategy, new product launches and brand planning.

I'm excited to share that what started as a shared vision has now grown into a meaningful collaboration - together, we'll be working on projects that turn these insights into actionable steps that truly benefit patients.

If you're interested in learning more about our work and how we're making a difference, please feel free to book a time on my calendar for a chat (link in comments).

You won't want to miss it!

Related Questions

What are some of Mark Sterckel's most notable achievements in the healthcare industry?
How has Mark Sterckel's experience at Roche influenced his approach to patient engagement?
What innovative technologies has Mark Sterckel implemented in his career?
How does Mark Sterckel foster innovation within large teams?
What are the key components of Mark Sterckel's patient engagement strategies?
Mark Sterckel
Mark Sterckel, photo 1
Mark Sterckel, photo 2
Add to my network

Experience

VP Patient Engagement / Chief Patient Officer
Senior Director Global Patient Advocacy Neurology, NF1 and Pipeline at Alexion Pharmaceuticals, Inc. (July 2022 - September 2023), Sr. Patient Engagement Director at Ferring Pharmaceuticals (July 2020 at Roche (August 2018 - July 2020)

Location

Küssnacht am Rigi, Schwyz, Switzerland